When Should Myelofibrosis Mutational Testing Be Repeated?
https://vimeo.com/1010017398 When should myelofibrosis mutational testing be repeated? Dr. Pemmaraju discusses the importance of retesting at key points and how mutations impact care and treatment plans. Dr. Naveen Pemmaraju is…
How Are Prognostic Scoring Systems Used in Myelofibrosis Care?
https://vimeo.com/1010017372 How are scoring systems such as DIPSS used in myelofibrosis care? Dr. Pemmaraju explains how these tools assess myelofibrosis prognosis and guide treatment decisions. Dr. Naveen Pemmaraju is Director…
Emerging Treatments in Myelofibrosis Care
https://vimeo.com/1010017316 Dr. Naveen Pemmaraju from MD Anderson Cancer Center discusses emerging myelofibrosis therapies currently in Phase II and III trials, including novel agents and combination treatments that show promise for…
What Myelofibrosis Treatment Types Are Available?
https://vimeo.com/1010017279 Dr. Naveen Pemmaraju outlines available myelofibrosis therapies, such as JAK inhibitors, and discusses the role of clinical trials and emerging treatments for managing the disease. Dr. Naveen Pemmaraju is…
Myelofibrosis Care | The Impact of Test Results
https://vimeo.com/1010017211 How do test results impact myelofibrosis care? Dr. Naveen Pemmaraju outlines essential tests like bone marrow biopsies and molecular testing and shares how results may guide treatment and prognosis….
Elevate | What You Should Know About Your Role in Myelofibrosis Treatment and Care Decisions
https://vimeo.com/1008523323 How can you elevate your overall myelofibrosis care and treatment? Dr. Naveen Pemmaraju discusses the importance of engaging in myelofibrosis care decisions with your healthcare team, shares advice for…